Unicycive Therapeutics

IPO

Unicycive Therapeutics is a biotech company in Mountain View, United States, founded in 2016. It has raised $134.0M across 6 rounds, most recently a $50.0M Corporate Round in March 2024.

Home - Unicycive

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$134.0M
Last Round
$50.0M Corporate RoundMar 2024
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds for this company. The full record is or through the API.

About

Unicycive Therapeutics is a biotechnology company founded in 2016 to accelerate kidney-disease innovation by identifying overlooked assets and developing them into therapies. Its pipeline includes oxylanthanum carbonate (OLC) for hyperphosphatemia in chronic kidney disease patients on dialysis, whose New Drug Application the FDA accepted in 2024, and UNI-494, which completed a Phase 1 study in healthy volunteers. The company, listed on NASDAQ as UNCY, focuses on closing urgent gaps in kidney care by moving undervalued technologies through clinical development with speed and efficiency for patients and providers.

Summary

It lists 11–50 employees. It has raised $134.0M in total across 6 rounds, most recently a $50.0M Corporate Round in Mar 2024.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundMar 2024
$50.0M

Sign up to see all 7 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Unicycive Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/unicycive-therapeutics"><img src="https://indexed.vc/api/badge/company/unicycive-therapeutics" alt="Unicycive Therapeutics on Indexed.vc" width="260" height="76" /></a>